Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
12.52
-0.46 (-3.51%)
At close: Apr 28, 2026, 4:00 PM EDT
12.54
+0.02 (0.20%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $468.19 million as of April 28, 2026. Its market cap has increased by 338.18% in one year.
Market Cap
468.19M
Enterprise Value
213.55M
1-Year Change
338.18%
Ranking
Category
Stock Price
$12.52
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $468.19M, an increase of 16.44%. That is a compound annual growth rate of 7.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 484.25M | 15.98% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 469.16M |
| Ovid Therapeutics | 463.74M |
| Entrada Therapeutics | 460.80M |
| Climb Bio | 456.19M |
| Larimar Therapeutics | 451.89M |
| Candel Therapeutics | 450.47M |
| Ginkgo Bioworks Holdings | 449.36M |
| REGENXBIO | 445.97M |